Market Cap
₹2,399 Cr.
P/E
31.52
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
5.14%
3yr Average
15.19%
5yr Average
13.76%
Net Profit Margin
Latest
2.73%
3yr Average
5.82%
5yr Average
5.03%
ROCE
Latest
7.31%
3yr Average
16.81%
5yr Average
14.99%
Debt to Equity
Latest
0.03
3yr Average
0.04
5yr Average
0.13
Market Share
0% (as of Jul 22)
Anti - Diabetes - Market Share
0.07% (as of Jul 22)
Anti-Infectives - Market Share
1.58% (as of May 19)
Blood Related - Market Share
0% (as of Jul 22)
Cardiovascular - Market Share
0.04% (as of Nov 21)
Dermatology - Market Share
0.05% (as of Jul 22)
Gastro-Intestinal - Market Share
0.02% (as of Nov 18)
Gynecology - Market Share
2% (as of Mar 19)
Loratadine - Market Share in Europe
10% (as of Mar 19)
Loratadine - Market Share in Korea
90% (as of Mar 19)
Loratadine - Market Share in USA
0.01% (as of Aug 18)
Neurological - Market Share
0.01% (as of Jun 21)
Pain - Market Share
0.02% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.04% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.01% (as of Oct 21)
Stomatological - Market Share
0.05% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Home Diagnostics / Health

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Finished Formulations

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Active Pharmaceutical Ingredients (API) & Intermediates

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up -Active Pharmaceutical Ingredients (API) & Intermediates

Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Global DMFs filed (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Burnol
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis